Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Ann Marie Schmidt, … , Shi Fang Yan, David M. Stern
Ann Marie Schmidt, … , Shi Fang Yan, David M. Stern
Published October 1, 2001
Citation Information: J Clin Invest. 2001;108(7):949-955. https://doi.org/10.1172/JCI14002.
View: Text | PDF
Perspective

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

  • Text
  • PDF
Abstract

Authors

Ann Marie Schmidt, Shi Du Yan, Shi Fang Yan, David M. Stern

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Schematic depiction of a two-hit model of vascular perturbation mediated...
Schematic depiction of a two-hit model of vascular perturbation mediated by RAGE and its ligands. We hypothesize that the diabetic vessel wall displays increased expression of RAGE ligands and the receptor itself (first hit). In the presence of additional perturbation (second hit), such as ischemic stress, immune/inflammatory stimuli, physical stress, or modified lipoproteins, there is an exaggerated cellular response promoting formation of vascular lesions (rather than restitution of vascular homeostasis).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts